These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Satoskar AR; Bozza M; Rodriguez Sosa M; Lin G; David JR Infect Immun; 2001 Feb; 69(2):906-11. PubMed ID: 11159984 [TBL] [Abstract][Full Text] [Related]
4. Both host and parasite MIF molecules bind to chicken macrophages via CD74 surface receptor. Kim S; Cox CM; Jenkins MC; Fetterer RH; Miska KB; Dalloul RA Dev Comp Immunol; 2014 Dec; 47(2):319-26. PubMed ID: 25086294 [TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase. Fan H; Hall P; Santos LL; Gregory JL; Fingerle-Rowson G; Bucala R; Morand EF; Hickey MJ J Immunol; 2011 Apr; 186(8):4915-24. PubMed ID: 21411731 [TBL] [Abstract][Full Text] [Related]
6. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection. Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591 [TBL] [Abstract][Full Text] [Related]
7. The Phosphoenolpyruvate Carboxykinase Is a Key Metabolic Enzyme and Critical Virulence Factor of Barazandeh AF; Mou Z; Ikeogu N; Mejia EM; Edechi CA; Zhang WW; Alizadeh J; Hatch GM; Ghavami S; Matlashewski G; Marshall AJ; Uzonna JE J Immunol; 2021 Mar; 206(5):1013-1026. PubMed ID: 33462138 [TBL] [Abstract][Full Text] [Related]
8. Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment. Zhang M; Yan L; Kim JA Cancer Gene Ther; 2015 Oct; 22(10):463-74. PubMed ID: 26403072 [TBL] [Abstract][Full Text] [Related]
9. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. Jüttner S; Bernhagen J; Metz CN; Röllinghoff M; Bucala R; Gessner A J Immunol; 1998 Sep; 161(5):2383-90. PubMed ID: 9725234 [TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice. Malu DT; Bélanger B; Desautels F; Kelendji K; Dalko E; Sanchez-Dardon J; Leng L; Bucala R; Satoskar AR; Scorza T J Immunol; 2011 Jun; 186(11):6271-9. PubMed ID: 21518974 [TBL] [Abstract][Full Text] [Related]
12. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560 [TBL] [Abstract][Full Text] [Related]
13. Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer. Klemke L; De Oliveira T; Witt D; Winkler N; Bohnenberger H; Bucala R; Conradi LC; Schulz-Heddergott R Cell Death Dis; 2021 Feb; 12(2):155. PubMed ID: 33542244 [TBL] [Abstract][Full Text] [Related]
14. CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Ishikawa H; Hisaeda H; Taniguchi M; Nakayama T; Sakai T; Maekawa Y; Nakano Y; Zhang M; Zhang T; Nishitani M; Takashima M; Himeno K Int Immunol; 2000 Sep; 12(9):1267-74. PubMed ID: 10967021 [TBL] [Abstract][Full Text] [Related]
15. Leishmania major infection in major histocompatibility complex class II-deficient mice: CD8+ T cells do not mediate a protective immune response. Erb K; Blank C; Ritter U; Bluethmann H; Moll H Immunobiology; 1996 Jul; 195(2):243-60. PubMed ID: 8877400 [TBL] [Abstract][Full Text] [Related]
16. MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major. Lemos MP; Esquivel F; Scott P; Laufer TM J Exp Med; 2004 Mar; 199(5):725-30. PubMed ID: 14993255 [TBL] [Abstract][Full Text] [Related]